CoChat

Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers

Roberson, Rachel S., Kussick, Steven J., Vallieres, Eric, Chen, Szu-Yu J., Wu, Daniel Y. · 2005 · Cancer Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Accelerated cellular senescence (ACS) has been described for tumor cells treated with chemotherapy and radiation. Following exposure to genotoxins, tumor cells undergo terminal growth arrest and adopt morphologic and marker features suggestive of cellular senescence. ACS is elicited by a variety of chemotherapeutic agents in the p53-null, p16-deficient human non–small cell H1299 carcinoma cells. After 10 to 21 days, infrequent ACS cells (1 in 106) can bypass replicative arrest and reenter cell cycle. These cells express senescence markers and resemble the parental cells in their transcription profile. We show that these escaped H1299 cells overexpress the cyclin-dependent kinase Cdc2/Cdk1. The escape from ACS can be disrupted by Cdc2/Cdk1 kinase inhibitors or by knockdown of Cdc2/Cdk1 with small interfering RNA and can be promoted by expression of exogenous Cdc2/Cdk1. We also present evidence that ACS occurs in vivo in human lung cancer following induction chemotherapy. Viable tumors following chemotherapy also overexpress Cdc2/Cdk1. We propose that ACS is a mechanism of in vivo tumor response and that mechanisms aberrantly up-regulate Cdc2/Cdk1 promotes escape from the senescence pathway may be involved in a subset of tumors and likely accounts for tumor recurrence/progression.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-1270

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

See all 429

Metadata

Authors
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y.
Affiliations
  • VA Puget Sound Health Care System (US)
  • University of Washington (US)
  • 4Department of Surgery, University of Washington, Seattle, Washington
Venue
Cancer Research
Published
2005-04-01
Volume
65
Issue
7
Pages
2795-2803
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2139712402
Cited by
428
References
50
Citations by year
2026: 12 · 2025: 26 · 2024: 22 · 2023: 36 · 2022: 38 · 2021: 35 · 2020: 31 · 2019: 22 · 2018: 18 · 2017: 15 · 2016: 15 · 2015: 14 · 2014: 12 · 2013: 16 · 2012: 15
FWCI
8.19
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k08ca071928-05)
  • National Cancer Institute (K08CA71928)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
senescence escape, cyclin-dependent kinases, chemotherapy-induced senescence, H1299 cells, non-small cell lung cancer, CDK1 inhibitors, tumor recurrence, tumor progression, senescence markers
MeSH terms
Antineoplastic Combined Chemotherapy Protocols, Caffeine, Camptothecin, Carcinoma, Non-Small-Cell Lung, Cell Division, Humans, Lung Neoplasms, Research Support as Topic, Transcription, Genetic, Randomized Controlled Trials as Topic, Tumor Suppressor Protein p53, Carboplatin, G2 Phase, CDC2 Protein Kinase, Cellular Senescence, Paclitaxel, Neoadjuvant Therapy, RNA, Small Interfering, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-1270
The paper
Roberson, R. S., Kussick, S. J., Vallieres, E., Chen, S.-Y. J., & Wu, D. Y. (2005). Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-1270

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.